Our results show that the combination of IL-15 with higher doses of the ADU-S100 analog led to a significant increase in cancer cell death when compared to the presence of IL-15 or ADU-S100 alone or PBS with PC3 and LNCaP cell lines. This evidence concerns the gene IL15 and cancer.